Finding Clinical Trials on Steroid-Induced Hyperglycemia
To find clinical trials on steroid-induced hyperglycemia, use ClinicalTrials.gov and search for "steroid-induced hyperglycemia" or "glucocorticoid hyperglycemia" as these are the most specific search terms that will yield relevant results.
Understanding Steroid-Induced Hyperglycemia
Steroid-induced hyperglycemia is a common complication affecting 10-60% of patients receiving glucocorticoid therapy 1. This condition significantly increases mortality and morbidity risk through infections and cardiovascular events.
Key characteristics:
- Occurs in both patients with and without pre-existing diabetes
- Develops rapidly, often within 48 hours of starting steroid therapy 2
- When prednisone is administered as a morning dose, glucose levels typically peak in the afternoon 2
- The highest glucose concentrations are typically detected on the 3rd day of steroid therapy, 2 hours after meals 3
Specific Search Strategy for Clinical Trials
Primary resource: ClinicalTrials.gov
- Use the advanced search function
- Enter search terms: "steroid-induced hyperglycemia" OR "glucocorticoid hyperglycemia" OR "steroid diabetes"
- Filter by "Recruiting" status if you want active trials
Additional databases to search:
- WHO International Clinical Trials Registry Platform (ICTRP)
- EU Clinical Trials Register
- ISRCTN registry
- PubMed Clinical Queries (filter for "Clinical Trial")
Search term combinations to try:
- "dexamethasone AND hyperglycemia"
- "prednisone AND diabetes"
- "glucocorticoid AND insulin resistance"
- "steroid AND glucose monitoring"
Key Topics in Current Research
When searching for trials, focus on these important areas of investigation:
Monitoring protocols
- Trials evaluating blood glucose monitoring every 2-4 hours during initial steroid therapy 1
- Studies on continuous glucose monitoring during steroid therapy
Insulin management approaches
Dose-response relationships
Prevention strategies
- Trials testing preventive measures for high-risk patients
- Studies on oral agents for postprandial hyperglycemia management
Practical Tips for Finding Relevant Trials
Filter by population characteristics:
- Non-diabetic patients receiving steroids
- Diabetic patients requiring steroid therapy
- Specific conditions requiring steroids (e.g., COPD, rheumatic diseases)
Look for specific outcome measures:
- Blood glucose control
- Insulin requirements
- Hyperglycemia prevention
- Quality of life impacts
Consider intervention types:
- Insulin protocols
- Oral antidiabetic agents
- Monitoring technologies
- Educational interventions
Contact research centers:
- Major academic medical centers often have endocrinology departments conducting relevant research
- Diabetes research centers may have unpublished or upcoming trials
Common Pitfalls When Searching for These Trials
Terminology variation: Some trials may use "glucocorticoid-induced diabetes" rather than "hyperglycemia"
Hidden within broader studies: Steroid-induced hyperglycemia may be a secondary outcome in trials focused on the primary condition requiring steroid treatment
Overlooking relevant populations: Trials in specific populations (e.g., transplant recipients, oncology patients) may have valuable data but not appear in general searches
Missing observational studies: While not interventional trials, observational studies may provide valuable insights into management approaches
By following this structured approach, you can effectively identify relevant clinical trials investigating steroid-induced hyperglycemia and stay informed about the latest research in this important clinical area.